| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 2334470 |
|---|
| Description | Potent 3-phosphoinositide-dependent protein kinase (PDPK1) inhibitor (IC50 ~ 10 nM). Exhibits no effect on other kinases including Aurora, ROCK, p38 MAPK and PI 3-K. Suppresses T-loop phosphorylation and subsequent activation of PDK1 substrates S6K1, SGK and RSK in vitro; exhibits limited inhibitory effect on Akt activation. Delays melanomagenesis and metastasis in BrafV600E::Pten(-/-) mice. Purity 98%. MW (observed): 462.59 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide |
|---|
| Gene, Accession, CAS # | CAS: 1227911-45-6 |
|---|
| Catalog # | 4143/10 |
|---|
| Price | |
|---|
| Order / More Info | GSK 2334470 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 24762669, 25446031, 26421002 |
|---|
| 產(chǎn)品資料 |
|
|